Product Name |
Remdesivir Nucleoside Monophosphate Ammonium salt |
Alternate Names |
Remdesivir Impurities, Impurities of Remdesivir |
CAT No. |
CS-O-35967
|
CAS No. |
1911578-74-9 (free base) |
Category |
Impurities |
Stock |
IN-Stock
|
Mol. Wt. |
405.30 g/mol |
Mol. For. |
C₁₂H₂₀N₇O₇P
|
Hazardous |
This is a Hazardous Compound
|
COA |
View Sample COA
|
MSDS |
View Sample MSDS
|
Parent API |
Remdesivir |
Controlled |
No |
Shipping |
Free for purchase above 1000$ |
Delivery |
In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
Return |
Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
Ordering |
Place your order online or by email sales@clearsynth.com |
If you find a better price anywhere else we guarantee Price match.
Remdesivir Nucleoside Monophosphate Ammonium salt is a novel antiviral drug that has shown promise in the treatment of COVID-19. It is a prodrug of Remdesivir, which is an adenosine analogue that inhibits the replication of RNA viruses. The ammonium salt form of Remdesivir Nucleoside Monophosphate is more soluble and stable than the free acid form, which makes it easier to administer as a drug.
Remdesivir Nucleoside Monophosphate Ammonium salt works by blocking the activity of the RNA-dependent RNA polymerase enzyme, which is essential for the replication of RNA viruses. This prevents the virus from multiplying and reduces the severity of the infection. It has been shown to be effective against a range of RNA viruses, including SARS-CoV-2, the virus that causes COVID-19.
The chemical formula of Remdesivir Nucleoside Monophosphate Ammonium salt is C27H35N6O8P.NH3, and it has a molecular weight of 664.6 g/mol. It is a white or off-white powder that is soluble in water and organic solvents.
The recommended dosage of Remdesivir Nucleoside Monophosphate Ammonium salt for the treatment of COVID-19 is 200 mg on the first day, followed by 100 mg once daily for the next four days. It is administered intravenously under medical supervision, and patients are closely monitored for any adverse effects. Overall, Remdesivir Nucleoside Monophosphate Ammonium salt is a promising drug that has the potential to save lives and reduce the impact of COVID-19 on global health.